Table 3.

Results of network meta-analysis for leucopenia (upper right quadrant) and gastrointestinal side effects (lower left quadrant).

AD+CT	3.29 (1.51,7.52)	0.72 (0.14,3.64)	1.08 (0.27,4.17)	0.42 (0.12,1.44)	1.98 (0.41,9.73)	0.91 (0.23,3.47)
2.73 (0.74,10.7)	CT	0.22 (0.051,0.88)	0.33 (0.10,0.97)	0.13 (0.049,0.32)	0.60 (0.15,2.31)	0.28 (0.090,0.78)
0.59 (0.037,9.20)	0.22 (0.019,2.37)	SF+CT	1.50 (0.25,9.08)	0.59 (0.11,3.22)	2.73 (0.39,19.88)	1.26 (0.21,7.27)
0.72 (0.080,6.45)	0.26 (0.045,1.47)	1.22 (0.063,24.56)	SQFZ+CT	0.39 (0.092,1.67)	1.83 (0.32,10.84)	0.84 (0.18,3.96)
0.93 (0.15,5.50)	0.34 (0.095,1.08)	1.59 (0.10,22.88)	1.3 (0.15,10.31)	CKS+CT	4.65 (0.92,24.58)	2.13 (0.50,8.72)
1.13 (0.075,17.27)	0.42 (0.038,4.40)	1.92 (0.066,58.5)	1.58 (0.083,29.94)	1.22 (0.086,18.41)	HCS+CT	0.46 (0.080,2.50)
1.34 (0.088,21.66)	0.49 (0.044,5.36)	2.28 (0.076,70.44)	1.87 (0.097,36.95)	1.43 (0.10,22.89)	1.18 (0.041,35.28)	XAP+CT
1.05 (0.015,41.99)	0.39 (0.0066,11.68)	1.77 (0.017,118.3)	1.46 (0.018,68.67)	1.13 (0.017,43.76)	0.92 (0.0088,59.64)	1.29 (0.020,138)	EL+CT

AD, Aidi injection; SF, Shenfu injection; SQFZ, Shenqi Fuzheng injection; KLT, Kanglaite injection; EL, elemene injection; XAP, Xiaoaiping injection; CKS, Compound Kushen injection; HCS, Huachansu injection; CT, chemotherapy.